DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

Adverse drug reactions:   

Frequency not Defined  

Blurred vision   

conjunctivitis   

intraocular pressure   

ocular exudate photophobia

Pregnancy warnings:     

AU TGA pregnancy category: B2
US FDA pregnancy category: C 

Breastfeeding warnings:  

The release of the drug into the human breastmilk is unknown 

Pregnancy Categories:      

Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.      

Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women      

Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women      

Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits      

Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.      

Category N: There is no data available for the drug under this category

Patient Information Leaflet  

Generic Name: homatropine  

Pronunciation: hoe-ma-TROE-peen 

Why do we use homatropine? 

homatropine belongs to the class Anticholinergic Agent and subclass Mydriatic used to treat uveitis and refraction. And this helps in dilating the pupil.